Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effects of rifampicin on global gene expression in human small intestine.

Oscarson M, Burk O, Winter S, Schwab M, Wolbold R, Dippon J, Eichelbaum M, Meyer UA.

Pharmacogenet Genomics. 2007 Nov;17(11):907-18.

PMID:
18075461
2.

Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.

Coller JK, Krebsfaenger N, Klein K, Wolbold R, Nüssler A, Neuhaus P, Zanger UM, Eichelbaum M, Mürdter TE.

Br J Clin Pharmacol. 2004 Jan;57(1):105-11.

3.

Sex is a major determinant of CYP3A4 expression in human liver.

Wolbold R, Klein K, Burk O, Nüssler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM.

Hepatology. 2003 Oct;38(4):978-88.

PMID:
14512885
4.

Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

Koch I, Weil R, Wolbold R, Brockmöller J, Hustert E, Burk O, Nuessler A, Neuhaus P, Eichelbaum M, Zanger U, Wojnowski L.

Drug Metab Dispos. 2002 Oct;30(10):1108-14.

PMID:
12228187
5.

The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

Coller JK, Krebsfaenger N, Klein K, Endrizzi K, Wolbold R, Lang T, Nüssler A, Neuhaus P, Zanger UM, Eichelbaum M, Mürdter TE.

Br J Clin Pharmacol. 2002 Aug;54(2):157-67.

6.

Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.

Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H, Klein K, Fromm MF, Nuessler AK, Neuhaus P, Zanger UM, Eichelbaum M, Wojnowski L.

J Biol Chem. 2002 Jul 5;277(27):24280-8. Epub 2002 Apr 8.

7.

The genetic determinants of the CYP3A5 polymorphism.

Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L.

Pharmacogenetics. 2001 Dec;11(9):773-9.

PMID:
11740341

Supplemental Content

Loading ...
Support Center